Breast Cancer: Targets and Therapy
Volume 12, 2020 - Issue
Open access
435
Views
14
CrossRef citations to date
0
Altmetric
Review
Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives
Monica IorfidaDivision of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, Italy
https://orcid.org/0000-0001-9654-8385
Manuelita MazzaDivision of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, Italy
& Elisabetta MunzoneDivision of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-3371-3878
Pages 45-56
|
Published online: 18 Mar 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.